1,25-Dihydroxyvitamin D <sub>3</sub> Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A

Sneha Joshi(Rutgers, The State University of New Jersey), Sawsan Youssef(Stanford University), Sarah L. Gaffen(University of Pittsburgh), Xikui K. Liu(University at Buffalo, State University of New York), Lawrence Steinman(Stanford University), Christine Rohowsky‐Kochan(Rutgers, The State University of New Jersey), Sylvia Christakos(Rutgers, The State University of New Jersey), Hong Liu(Shenyang Medical College), Akihiko Yoshimura(Keio University), Luiz-Carlos Pantalena(Stanford University), Kenji Ichiyama(The University of Osaka)
Molecular and Cellular Biology
July 12, 2011
10.1128/mcb.05020-11
Cited by 456

Related Papers

Regulatory T Cells and Human Disease
|Annual Review of Immunology|2020|1.1k
Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
|The Journal of Experimental Medicine|2009|999
A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors.
|The EMBO Journal|1995|758
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
|Nature|2008|519
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
|Nature Medicine|2000|515